Condition: Carbapenem Resistant Bacterial Infection · Acinetobacter Bacteremia · Acinetobacter Pneumonia · Sponsor: Rambam Health Care Campus
Patients with bloodstream infections, hospital acquired pneumonia or ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii (CRAB) treated with cefiderocol combined with ampicillin sulbactam will be compared to patients treated treated with colistin alone or colistin combined with meropenem.
This description comes directly from the study's public registry record.
Mical Paul · 0502062140 · paulm@technion.ac.il
Marco Falcone · marco.falcone@unipi.it
Always discuss trial participation with your own doctor first.
| Rambam Health Care Campus | Haifa, Israel | Recruiting |
| Sheba Tel HaShomer Medical Campus | Ramat Gan, Israel | Recruiting |
| Shamir Medical Center (Assaf Harofeh) | Tel Aviv, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05922124